Answers to the antiphospholipid-antibody syndrome?

New England Journal of Medicine

Volumn 332, Issue 15, 1995, Pages 1025-1027

  Lockshin, Michael D ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIBODY DETECTION; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVEDO RETICULARIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTOPENIA;

ANTIPHOSPHOLIPID SYNDROME; HUMAN; THROMBOSIS; WARFARIN;

EID: 0028920827     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199504133321510     Document Type: Editorial

References (12)

1. Lockshin MD Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20.: 45-59
2. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS Anticardiolipin antibodies in systemic lupus erythematosus.: clinical correlates, HLA associations, and impact on survival. J Rheumatol 1993; 20.: 1684-1693
3. Inbar O, Blank M, Faden D, Tincani A, Lorber M, Shoenfeld Y Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. Am J Obstet Gynecol 1993; 169.: 423-426
4. Pierangeli SS, Barker JH, Stikovac D, Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994; 71.: 670-674
5. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L Repeated fetal losses associated with antiphospholipid antibodies.: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166.: 1318-1323
6. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169.: 1411-1417
7. Brey RL Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994; 3.: 299-302
8. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332.: 993-997
9. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR Outcome of treated pregnancies in women with antiphospholipid syndrome.: an update of the Utah experience. Obstet Gynecol 1992; 80.: 614-620
10. Salzman EW Low-molecular-weight heparin and other new antithrombotic drugs. N Engl J Med 1992; 326.: 1017-1019
11. Fishman P, Falach-Vaknine E, Zigelman R, Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 1993; 91.: 1834-1837
12. Shoenfeld Y, Blank M Effect of long-acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome. Lupus 1994; 3.: 397-400